92 Biggest Movers From Yesterday

Author: Lisa Levin | March 05, 2020 05:41am

Gainers

Cellect Biotechnology Ltd. (NASDAQ:APOP) shares jumped 45% to close at $3.03 on Wednesday. Cellect Biotechnology and Canndoc Ltd. agreed to enter into strategic pharma grade cannabis commercial deal for reduction in opioid usage.
Heat Biologics, Inc. (NASDAQ:HTBX) climbed 35.9% to close at $0.8200 after declining around 25% on Tuesday.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) jumped 32.4% to close at $7.23. Raymond James upgraded Ocular Therapeutix from Outperform to Strong Buy and raised the price target from $7 to $15.
AIM ImmunoTech Inc. (NYSE:AIM) gained 30.1% to close at $2.38 after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) surged 28.1% to close at $3.83.
VectoIQ Acquisition Corp. (NASDAQ:VTIQ) shares gained 27.8% to close at $14.70.
The Meet Group, Inc. (NASDAQ:MEET) rose 23.1% to close at $6.82 amid a Reuters report that NuCom Group is nearing a deal for company.
eHealth, Inc. (NASDAQ:EHTH) shares gained 21.9% to close at $146.09. eHealth priced its 1.8 million share follow-on offering of common stock at $115 per share.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) surged 21.7% to close at $11.28 following Q4 results. Barclays initiated coverage on Syndax Pharmaceuticals with an Overweight rating and a $15 price target.
Trillium Therapeutics Inc. (NASDAQ:TRIL) gained 20.7% to close at $7.00 after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.
Glowpoint, Inc. (NYSE:GLOW) rose 20.5% to close at $2.53 after surging around 50% on Tuesday.
Vivint Smart Home, Inc. (NYSE:VVNT) shares gained 19.6% to close at $25.10.
RAPT Therapeutics, Inc. (NASDAQ:RAPT) gained 18.8% to close at $22.26.
Atreca, Inc. (NASDAQ:BCEL) rose 18.7% to close at $27.28.
Digital Turbine, Inc. (NASDAQ:APPS) gained 18.5% to close at $6.92. Digital Turbine completed the acquisition of Mobile Posse.
Viela Bio, Inc. (NASDAQ:VIE) shares rose 18.4% to close at $52.88.
Cooper-Standard Holdings Inc. (NYSE:CPS) surged 18% to close at $16.17.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shares jumped 17.7% to close at $3.86.
Inpixon (NASDAQ:INPX) gained 17.5% to close at $2.55 after the company reported FY19 sales results up from last year.
Baudax Bio, Inc. (NASDAQ:BXRX) jumped 17.1% to close at $7.61.
Barnes & Noble Education, Inc. (NYSE:BNED) gained 16.5% to close at $3.67.
Molina Healthcare, Inc. (NYSE:MOH) surged 16.3% to close at $142.35.
IGM Biosciences, Inc. (NASDAQ:IGMS) jumped 16.1% to close at $73.75.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) shares gained 15.9% to close at $4.24.
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares gained 15.7% to close at $16.78 after the company disclosed a partnership with Duke-NUS Medical School to develop coronavirus vaccine using STARR technology. The company won $14.039 million grant from Singapore Economic Development Board to support co-development of coronavirus vaccine.
Blue Apron Holdings, Inc. (NYSE:APRN) shares rose 15.7% to close at $2.72.
Anthem, Inc. (NYSE:ANTM) jumped 15.6% to close at $296.42 after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.
Centene Corporation (NYSE:CNC) shares surged 15.6% to close at $62.46.
Soleno Therapeutics, Inc. (NASDAQ:SLNO) shares rose 15.5% to close at $3.28.
NuCana plc (NASDAQ:NCNA) gained 15.3% to close at $9.05. NuCana received positive opinion for orphan drug designation in European Union for Acelarin (NUC-1031) for treatment of patients with biliary tract cancer.
Morphic Holding, Inc. (NASDAQ:MORF) surged 14.8% to close at $17.95.
ClearOne, Inc. (NASDAQ:CLRO) rose 14.7% to close at $2.33.
Humana Inc. (NYSE:HUM) gained 14.4% to close at $372.34.
aTyr Pharma, Inc. (NASDAQ:LIFE) rose 14.3% to close at $4.25.
Dynatronics Corporation (NASDAQ:DYNT) surged 14.1% to close at $2.02.
IMV Inc. (NASDAQ:IMV) shares rose 14.1% to close at $2.75.
Maxar Technologies Inc. (NYSE:MAXR) jumped 14% to close at $17.56.
Livongo Health, Inc. (NASDAQ:LVGO) shares rose 13.8% to close at $27.64.
iCAD, Inc. (NASDAQ:ICAD) shares gained 13.4% to close at $14.14.
Theratechnologies Inc. (NASDAQ:THTX) shares rose 13.4% to close at $3.21.
CareDx, Inc (NASDAQ:CDNA) gained 13.3% to close at $24.27.
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shares rose 13.2% to close at $9.03.
OneSpan Inc. (NASDAQ:OSPN) climbed 13.1% to close at $18.50 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY20 sales guidance above analyst estimates.
ADMA Biologics, Inc. (NASDAQ:ADMA) jumped 13% to close at $3.39. ADMA Biologics shares climbed Tuesday after the company received a notice of allowance for a patent application for its portfolio encompassing immunoglobulin plasma pool compositions used in the manufacturing of ASCENIV.
DURECT Corporation (NASDAQ:DRRX) rose 12.8% to close at $1.94 after the company reported better-than-expected Q4 sales.
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) gained 12.8% to close at $9.33.
Veritone, Inc. (NASDAQ:VERI) gained 12.7% to close at $3.37.
Guardant Health, Inc. (NASDAQ:GH) gained 12.4% to close at $83.20 after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.
Cronos Group Inc. (NASDAQ:CRON) surged 12% to close at $5.96.
Designer Brands Inc. (NYSE:DBI) shares gained 11.8% to close at $14.53.
Tenet Healthcare Corporation (NYSE:THC) shares jumped 11.4% to close at $28.76.
Homology Medicines, Inc. (NASDAQ:FIXX) shares gained 11.3% to close at $22.04.
Cornerstone Building Brands, Inc. (NYSE:CNR) rose 10.9% to close at $8.13 following better-than-expected quarterly results.
2U, Inc. (NASDAQ:TWOU) surged 10.9% to close at $28.28.
Cigna Corporation (NYSE:CI) rose 10.7% to close at $209.54 after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.
UnitedHealth Group Incorporated (NYSE:UNH) rose 10.7% to close at $289.42 after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.
500.com Limited (NYSE:WBAI) shares surged 9.7% to close at $6.58.
Vir Biotechnology Inc (NASDAQ:VIR) rose 9.6% to close at $44.90 after the company and Alnylam expanded their collaboration to advance RNAi treatments for coronavirus infection.
VIVUS, Inc. (NASDAQ:VVUS) climbed 9% to close at $1.82 after the company reported better-than-expected Q4 earnings.
Neuronetics, Inc. (NASDAQ:STIM) shares gained 8.1% to close at $2.68.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares gained 7.7% to close at $8.02. Inovio Pharmaceuticals shares jumped around 70% on Tuesday after the company announced an accelerated timeline of developing DNA Vaccine INO-4800 for the Coronavirus.
Benefitfocus, Inc. (NASDAQ:BNFT) gained 6.8% to close at $12.20 following upbeat quarterly earnings.
GenMark Diagnostics, Inc. (NASDAQ:GNMK) rose 6.7% to close at $4.57. GenMark Diagnostics shares climbed 22% on Tuesday after the company found support from COVID-19 related news.
Yext Inc (NYSE:YEXT) rose 5.5% to close at $15.29 after the company reported better-than-expected Q4 results.
Beyond Air, Inc. (NASDAQ:XAIR) gained 5.2% to close at $10.93.

Check out these big penny stock gainers and losers

Losers

Cardlytics, Inc. (NASDAQ:CDLX) shares tumbled 36.7% to close at $54.55 on Wednesday after the company reported Q4 earnings results. Craig-Hallum also downgraded the stock from Buy to Hold.
Recro Pharma, Inc. (NASDAQ:REPH) fell 23.3% to close at $11.00 after the company reported results for the year ended 2019.
Allied Healthcare Products, Inc. (NASDAQ:AHPI) fell 19.3% to close at $16.14 after surging around 28% on Tuesday.
OpGen, Inc. (NASDAQ:OPGN) shares dipped 18.1% to close at $3.21.
Infinera Corporation (NASDAQ:INFN) tumbled 16.8% to close at $5.89 after the company announced a proposed $200 million convertible senior notes offering.
Alpha Pro Tech, Ltd. (NYSE:APT) shares declined 16.6% to close at $16.00 after rising around 20% on Tuesday.
Midatech Pharma plc (NASDAQ:MTP) fell 16.6% to close at $2.36.
Co-Diagnostics, Inc. (NASDAQ:CODX) dipped 16.4% to close at $12.00.
Borr Drilling Limited (NYSE:BORR) declined 15.1% to close at $1.52 after dropping around 7% on Tuesday.
Veritiv Corporation (NYSE:VRTV) fell 13.7% to close at $10.11.
Stealth BioTherapeutics Corp (NASDAQ:MITO) dipped 13% to close at $2.67.
CLPS Incorporation (NASDAQ:CLPS) shares declined 12.9% to close at $2.22.
Altimmune, Inc. (NASDAQ:ALT) fell 12.6% to close at $2.85.
Aptorum Group Limited (NASDAQ:APM) shares tumbled 12.2% to close at $4.95.
111, Inc. (NASDAQ:YI) dipped 12% to close at $6.17.
Hebron Technology Co., Ltd. (NASDAQ:HEBT) declined 11.1% to close at $8.00.
Owens & Minor, Inc. (NYSE:OMI) fell 10.5% to close at $6.03 after the company reported worse-than-expected Q4 sales. The company also issued FY20 EPS guidance below analyst estimates.
Ituran Location and Control Ltd. (NASDAQ:ITRN) dropped 10.2% to close at $20.01 after reporting downbeat Q4 results.
Frank's International N.V. (NYSE:FI) dipped 10.1% to close at $3.28.
Intelsat S.A. (NYSE:I) shares fell 9.8% to close at $3.13.
Evolus, Inc. (NASDAQ:EOLS) dropped 9.2% to close at $7.43.
Recon Technology, Ltd. (NASDAQ:RCON) fell 8.9% to close at $2.35.
Health Insurance Innovations Inc (NASDAQ:HIIQ) dropped 8.6% to close at $25.67 after the company reported worse-than-expected Q4 sales. The company also issued FY20 EPS guidance below estimates.
OpGen, Inc. (NASDAQ:OPGN) shares fell 8.1% to close at $3.21 after rising around 15% on Tuesday.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares declined 7.5% to close at $2.70.
Urban Outfitters, Inc. (NASDAQ:URBN) fell 7.5% to close at $21.40 after the company reported downbeat results for its fourth quarter on Tuesday.
Atento S.A. (NYSE:ATTO) shares declined 5.9% to close at $2.70 after reporting Q4 results.